Caption Management, LLC Avadel Pharmaceuticals PLC Put Options Transaction History

Caption Management, LLC

  • $5.74 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
BUY
$12.55 - $17.22 $112,950 - $154,980
9,000 New
9,000 $152,000
Q1 2022

May 13, 2022
SELL
$5.46 - $8.29 $1.53 Million - $2.32 Million
-279,500 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$7.34 - $11.18 $1.68 Million - $2.57 Million
229,500 Added 459.0%
279,500 $2.26 Million
Q1 2021

May 17, 2021
BUY
$6.61 - $10.07 $330,500 - $503,500
50,000 New
50,000 $453,000

Others Institutions Holding AVDL

# of Institutions
8
Shares Held
1.07M
Call Options Held
0
Put Options Held
0
View Full List

About AVADEL PHARMACEUTICALS PLC

AVDL Quotes by TradingView
  • Ticker AVDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,581,300
  • Market Cap $650M
  • Description
  • Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...
More about AVDL
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email